Karl Kieburtz

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.

Arthur W Toga, Tanya Simuni, Christopher S Coffey, 2013, JAMA neurology.

HIV-associated cognitive impairment before and after the advent of combination therapy

Yaakov Stern, Karen Marder, Giovanni Schifitto, 2011, Journal of NeuroVirology.

Enhancing Clinical Research Professionals’ Training and Qualifications (ECRPTQ): Recommendations for Good Clinical Practice (GCP) training for investigators and study coordinators

Richard Barohn, Katherine Luzuriaga, Harry P. Selker, 2017, Journal of Clinical and Translational Science.

Education and training of clinical and translational study investigators and research coordinators: A competency-based approach

Richard Barohn, Katherine Luzuriaga, Harry P. Selker, 2017, Journal of Clinical and Translational Science.

Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort

Norbert Schuff, Arthur W. Toga, John Seibyl, 2018, Movement disorders : official journal of the Movement Disorder Society.

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.

Tanya Simuni, Jordan J Elm, Debra Babcock, 2015, JAMA.

Non-linearity of Parkinson’s disease progression: implications for sample size calculations in clinical trials

Yuko Y Palesch, Jordan J Elm, Bernard Ravina, 2005, Clinical trials.

CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study

Arthur W. Toga, Leslie M. Shaw, John Q. Trojanowski, 2016, Acta Neuropathologica.

1.003 FACILITATING CLINICAL RESEARCH: THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS (NINDS) AND STROKE PARKINSON'S DISEASE COMMON DATA ELEMENTS PROJECT

Anthony E. Lang, Karen Marder, Daniel Weintraub, 2012 .